Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN

Watchlist Manager
Biohaven Pharmaceutical Holding Company Ltd Logo
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Watchlist
Price: 49.04 USD -2.62% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Biohaven Pharmaceutical Holding Company Ltd?
Write Note

Net Margin
Biohaven Pharmaceutical Holding Company Ltd

0%
Current
0%
Average
-7.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-746.6m
/
Revenue
0

Net Margin Across Competitors

Country US
Market Cap 4.5B USD
Net Margin N/A
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 301B USD
Net Margin
9%
Country US
Market Cap 162B USD
Net Margin
13%
Country US
Market Cap 127.5B USD
Net Margin
-5%
Country US
Market Cap 115.4B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 138B AUD
Net Margin
18%
Country US
Market Cap 88.6B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.1B EUR
Net Margin
-14%

Profitability Report

View the profitability report to see the full profitability analysis for Biohaven Pharmaceutical Holding Company Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-746.6m
/
Revenue
0
What is the Net Margin of Biohaven Pharmaceutical Holding Company Ltd?

Based on Biohaven Pharmaceutical Holding Company Ltd's most recent financial statements, the company has Net Margin of 0%.